(Q82975055)
Statements
Therapy for severe refractory acute graft-versus-host disease with basiliximab, a selective interleukin-2 receptor antagonist (English)
V A M Funke
C R de Medeiros
D C Setúbal
J Ruiz
M A Bitencourt
C M Bonfim
J Z Neto